{"role": "assistant", "content": null, "function_call": {"name": "get_risks", "arguments": "{\"risks\":[{\"Description\":\"Limited research in critical areas related to disease control and outbreak management\",\"Impact\":\"Lack of understanding and preparedness for disease control in critical areas\",\"Mitigation\":\"Increase funding and support for research in underexplored areas of disease control and outbreak management\",\"Technologies\":\"Data analytics, AI, and computational modeling for identifying research gaps\",\"People\":\"Researchers, public health organizations, policymakers\",\"Owner\":\"Research institutions, funding agencies, government\"},{\"Description\":\"Inadequate knowledge and understanding of infection risk factors based on age, gender, and location of the population\",\"Impact\":\"Increased vulnerability to disease outbreaks due to inadequate understanding of infection risk factors\",\"Mitigation\":\"Conduct targeted research on infection risk factors based on age, gender, and location of the population\",\"Technologies\":\"Epidemiological studies, data analytics, and geographic information systems (GIS)\",\"People\":\"Epidemiologists, public health researchers, statisticians\",\"Owner\":\"Research institutions, public health agencies\"},{\"Description\":\"Limited research on drug efficacy, safety, and antibody response\",\"Impact\":\"Risk of ineffective treatment and immunization strategies for disease outbreaks\",\"Mitigation\":\"Invest in research on drug efficacy, safety, and antibody response for improved treatment and immunization strategies\",\"Technologies\":\"Clinical trials, immunological assays, and drug screening technologies\",\"People\":\"Immunologists, pharmacologists, public health researchers\",\"Owner\":\"Pharmaceutical companies, research institutions\"}]}"}}